NU

Nilanjana Uzir Baruah

Director Director DIN 02840191
DIN 02840191 First appointment Sep 2004 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Sep 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Nilanjana Uzir Baruah

Data last updated:

Nilanjana Uzir Baruah was a Director at Landmark India Health And Wealth Solutio Ns Private Limited (2004–2010). The company operates in Healthcare.

DIN 02840191
Primary Designation Director
Industry Healthcare
First Appointment 15 Sep 2004

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Sep 20042004Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Landmark India Health And Wealth Solutio Ns Private Limited
Premium access

Shareholding and investment profile for Nilanjana Uzir Baruah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilanjana Uzir Baruah

Nilanjana Uzir Baruah was first appointed on 15 Sep 2004 as Director at Landmark India Health And Wealth Solutio Ns Private Limited.

Nilanjana Uzir Baruah held 1 earlier board appointment: Landmark India Health And Wealth Solutio Ns Private Limited (Director, 15 Sep 2004 to 27 Aug 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available